There are very few companies that hit all the crucial investment...

There are very few companies that hit all the crucial investment criteria on the  ASX.

EMV has it all.

Amazing tech- comes out of a reputable institution with over 10 years research

Management- Ron has done it before (NAN was a 100 bagger) , and Stuart is a genius.

Industry Support- GE has partnered to the tune of $1m (non-dilutive)  along with  hospitals

Government Support- Government has funded close to $2m in grants, and because stroke is such a hot topic there are more funding opportunities they can apply for. No cap raise anytime soon, if you want a piece of the action you got to buy on market.

Massive markets: Stroke and fatty liver are already huge markets and growing especially in the developing world.

Tight register/ Low mcap: The register looks to be the goods & the EV is extremely low compared to other companies on the ASX who just received ISO..Cough cough RAP.

In this market people will always find a reason not to buy, personally, I'm a fan of listing it in a bad market. Because in a good market everything flies, people take IPOs to flip, but in a bad market the people who put the funds in are not there for 20%, they are there for at least 4-5 times which is still only a $60m mcap. I expect I won't be the only one topping up tomorrow. DYOR